Benefit — Part 11 reproducibility
What Snapshot-grade Part 11 reproducibility actually saves you
The rule is electronic-records + audit-trail reproducibility. The consequence of NOT being able to reproduce an AI-driven eligibility decision when BIMO opens a Form 483 is a very different exposure profile.
The three moments where it matters
- FDA BIMO inspection. Inspector requests reproduction of a named eligibility decision from Day X. Ability to pin model version + input state + decision hash is the difference between a routine inspection close-out and a Form 483 observation.
- NDA/BLA reviewer question. Reviewer asks how a specific AI-driven eligibility call was made. Reproducibility on file lets Reg Affairs answer in the same review cycle rather than triggering a Complete Response Letter delay.
- Post-marketing plaintiff discovery. Plaintiff subpoenas AI-decision records tied to a specific enrollee. Retention discipline determines whether reproduction runs in-house or through outside forensics.
Dollar frame
FDA Form 483 remediation cost: a single Part 11 observation tied to AI-decision reproducibility typically drives $2M-$25M in regulatory-hold + amended-submission cycle cost. Public precedent for Part 11 483s in AI-touched trials is climbing.
CRL delay cost: a Complete Response Letter that adds even six months to an oncology-program timeline can cost $50M-$500M in lost exclusivity + competitive-erosion terms.
Preventive discipline cost: $499 Snapshot documents the reproducibility. Under BIMO close-out, that dated record is frequently what moves an observation from Form 483 to Voluntary Action Indicated.
Who at your org cares
- VP Regulatory Affairs — BIMO + NDA/BLA reviewer stance
- Chief Medical Officer — clinical-record defensibility
- Head of Clinical Operations — sponsor SOP + retention-pipeline reality
- General Counsel — discovery-response readiness
- Chief Quality Officer — sponsor quality-system integrity
What "having it" looks like
Green: BIMO inspector requests reproduction. Reg Affairs runs the same procedure the Snapshot rehearsed. Records produced in the inspection window. Close-out on merits, not on records-production gaps.
Red: Inspector requests reproduction. Clinical-AI vendor's decision trace rotated with the model. Reproduction requires forensic reconstruction. Form 483 observation crystallizes on records-management + Part 11 both.
$499. 3 business days.
The dated Part 11 reproducibility record BIMO + your Reg Affairs + your carrier want on file BEFORE the inspection lands.
Buy $499